Oncternal Therapeutics In... (ONCT)
NASDAQ: ONCT
· Real-Time Price · USD
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 10:00 PM
Oncternal Therapeutics Fail-to-Deliver
Total FTD Shares
1.65K
Below Average
FTD / Avg. Volume
2.65%
Low Impact
1-Year Change
-13.7%
Negative Trend
FTD Chart
As of Dec 2, 2024,
Oncternal Therapeutics Inc. has
1,650
shares failed to deliver, representing 2.65%
of the average daily volume of
62,268
shares. Over the past year, the monthly average FTD is
4,170
shares, with the current level 60% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Dec 02, 2024 | 0.53 | 1.65K | -74.75% |
| Nov 26, 2024 | 0.75 | 6.54K | +140.17% |
| Oct 30, 2024 | 1.5 | 2.72K | +1088.21% |
| Sep 17, 2024 | 1.48 | 229 | -19.37% |
| Aug 13, 2024 | 3.97 | 284 | +91.89% |
| Jul 11, 2024 | 7.26 | 148 | +105.56% |
| May 28, 2024 | 9.41 | 72 | +50.00% |
| Apr 19, 2024 | 8.86 | 48 | -11.11% |
| Mar 05, 2024 | 9.5 | 54 | +17.39% |
| Feb 20, 2024 | 8.6 | 46 | +318.18% |
| Jan 11, 2024 | 7.38 | 11 | -99.89% |
| Dec 29, 2023 | 10.72 | 10K | +423.29% |
| Nov 28, 2023 | 7 | 1.91K | +5871.88% |
| Sep 15, 2023 | 7 | 32 | -96.17% |
| Aug 09, 2023 | 7.2 | 835 | -88.90% |
| Jul 31, 2023 | 7.4 | 7.52K | +6221.01% |
| Jun 29, 2023 | 7 | 119 | -91.72% |
| May 24, 2023 | 6.4 | 1.44K | -34.22% |
| Apr 28, 2023 | 6.2 | 2.19K | -85.87% |
| Mar 22, 2023 | 14.2 | 15.47K | +53248.28% |
| Feb 27, 2023 | 18 | 29 | -81.17% |
| Jan 30, 2023 | 23.2 | 154 | n/a |